Literature DB >> 32452088

Rosette Trajectories Enable Ungated, Motion-Robust, Simultaneous Cardiac and Liver T2 * Iron Assessment.

Adam M Bush1, Christopher M Sandino2, Shreya Ramachandran3, Frank Ong1, Nicholas Dwork4, Evan J Zucker1, Ali B Syed1, John M Pauly2, Marcus T Alley1, Shreyas S Vasanawala1.   

Abstract

BACKGROUND: Quantitative T2 * MRI is the standard of care for the assessment of iron overload. However, patient motion corrupts T2 * estimates.
PURPOSE: To develop and evaluate a motion-robust, simultaneous cardiac and liver T2 * imaging approach using non-Cartesian, rosette sampling and a model-based reconstruction as compared to clinical-standard Cartesian MRI. STUDY TYPE: Prospective. PHANTOM/POPULATION: Six ferumoxytol-containing phantoms (26-288 μg/mL). Eight healthy subjects and 18 patients referred for clinically indicated iron overload assessment. FIELD STRENGTH/SEQUENCE: 1.5T, 2D Cartesian and rosette gradient echo (GRE) ASSESSMENT: GRE T2 * values were validated in ferumoxytol phantoms. In healthy subjects, test-retest and spatial coefficient of variation (CoV) analysis was performed during three breathing conditions. Cartesian and rosette T2 * were compared using correlation and Bland-Altman analysis. Images were rated by three experienced radiologists on a 5-point scale. STATISTICAL TESTS: Linear regression, analysis of variance (ANOVA), and paired Student's t-testing were used to compare reproducibility and variability metrics in Cartesian and rosette scans. The Wilcoxon rank test was used to assess reader score comparisons and reader reliability was measured using intraclass correlation analysis.
RESULTS: Rosette R2* (1/T2 *) was linearly correlated with ferumoxytol concentration (r2 = 1.00) and not significantly different than Cartesian values (P = 0.16). During breath-holding, ungated rosette liver and heart T2 * had lower spatial CoV (liver: 18.4 ± 9.3% Cartesian, 8.8% ± 3.4% rosette, P = 0.02, heart: 37.7% ± 14.3% Cartesian, 13.4% ± 1.7% rosette, P = 0.001) and higher-quality scores (liver: 3.3 [3.0-3.6] Cartesian, 4.7 [4.1-4.9] rosette, P = 0.005, heart: 3.0 [2.3-3] Cartesian, 4.5 [3.8-5.0] rosette, P = 0.005) compared to Cartesian values. During free-breathing and failed breath-holding, Cartesian images had very poor to average image quality with significant artifacts, whereas rosette remained very good, with minimal artifacts (P = 0.001). DATA
CONCLUSION: Rosette k-sampling with a model-based reconstruction offers a clinically useful motion-robust T2 * mapping approach for iron quantification. J. MAGN. RESON. IMAGING 2020;52:1688-1698.
© 2020 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  Iron; T2*; non-Cartesian; rosette

Mesh:

Substances:

Year:  2020        PMID: 32452088      PMCID: PMC7699670          DOI: 10.1002/jmri.27196

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  42 in total

1.  Reduced aliasing artifacts using variable-density k-space sampling trajectories.

Authors:  C M Tsai; D G Nishimura
Journal:  Magn Reson Med       Date:  2000-03       Impact factor: 4.668

2.  Self-gated cardiac cine MRI.

Authors:  Andrew C Larson; Richard D White; Gerhard Laub; Elliot R McVeigh; Debiao Li; Orlando P Simonetti
Journal:  Magn Reson Med       Date:  2004-01       Impact factor: 4.668

3.  Projection reconstruction techniques for reduction of motion effects in MRI.

Authors:  G H Glover; J M Pauly
Journal:  Magn Reson Med       Date:  1992-12       Impact factor: 4.668

4.  Analysis of generalized rosette trajectory for compressed sensing MRI.

Authors:  Ya Li; Ran Yang; Cishen Zhang; Jingxin Zhang; Sen Jia; Zhiyang Zhou
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

5.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

6.  An optimal radial profile order based on the Golden Ratio for time-resolved MRI.

Authors:  Stefanie Winkelmann; Tobias Schaeffter; Thomas Koehler; Holger Eggers; Olaf Doessel
Journal:  IEEE Trans Med Imaging       Date:  2007-01       Impact factor: 10.048

7.  Highly undersampled magnetic resonance image reconstruction via homotopic l(0) -minimization.

Authors:  Joshua Trzasko; Armando Manduca
Journal:  IEEE Trans Med Imaging       Date:  2009-01       Impact factor: 10.048

8.  Protocol optimization for cardiac and liver iron content assessment using MRI: What sequence should I use?

Authors:  Christian A Barrera; Hansel J Otero; Helge D Hartung; David M Biko; Suraj D Serai
Journal:  Clin Imaging       Date:  2019-02-20       Impact factor: 1.605

9.  Rapid measurement and correction of phase errors from B0 eddy currents: impact on image quality for non-Cartesian imaging.

Authors:  Ethan K Brodsky; Jessica L Klaers; Alexey A Samsonov; Richard Kijowski; Walter F Block
Journal:  Magn Reson Med       Date:  2012-04-05       Impact factor: 4.668

10.  Development of a tissue-equivalent MRI phantom using carrageenan gel.

Authors:  Koichi Yoshimura; Hirokazu Kato; Masahiro Kuroda; Atsushi Yoshida; Katsumi Hanamoto; Akio Tanaka; Masatoshi Tsunoda; Susumu Kanazawa; Koichi Shibuya; Shoji Kawasaki; Yoshio Hiraki
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

View more
  2 in total

1.  Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging.

Authors:  Jia-Yi Liu; Ye-Yu Cai; Zhu-Yuan Ding; Zi-Yi Zhou; Min Lv; Huan Liu; Li-Yun Zheng; Lan Li; Yong-Heng Luo; En-Hua Xiao
Journal:  J Magn Reson Imaging       Date:  2021-09-21       Impact factor: 5.119

2.  Cardiac MRF using rosette trajectories for simultaneous myocardial T1, T2, and proton density fat fraction mapping.

Authors:  Yuchi Liu; Jesse Hamilton; Yun Jiang; Nicole Seiberlich
Journal:  Front Cardiovasc Med       Date:  2022-09-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.